Startups
Dicronis GmbH
Edit

Dicronis GmbH

http://www.dicronis.com/
Last activity: 21.08.2019
Active
Categories: DiagnosticsHealthTechITLifeProductResearchSocietyTechnologyTimeWearables
Dicronis GmbH develops microneedles for diagnostic and therapeutic purposes. The first product in our pipeline, Lymphit, measures patient’s lymphatic function in a safe, home-based and highly-scalable manner. The initial indication of Lymphit is the earliest possible diagnosis of secondary lymphedema, a serious side effect of many cancer therapies. By monitoring the lymphatic function, the physician is enabled for the first time to perform an early diagnosis, before the swelling has occurred, and evaluate the best conservative treatment for the patient. This leads to a great improvement of the prognosis and quality-of-life of the patient and important savings for the healthcare system and society.
Followers
513
Mentions
10

Overview

Location
Switzerland, Zurich
Employees
1-10
Founded date
2018

FAQ about Dicronis GmbH

When was Dicronis GmbH founded?

Dicronis GmbH was founded in 2018.

Who has invested in Dicronis GmbH?

Parsers VC lists 2 investors of Dicronis GmbH, among them MassChallenge.

What has the press written about Dicronis GmbH?

Parsers VC has collected 10 articles mentioning Dicronis GmbH, among them “ZKB Pionierpreis TECHNOPARK: Die drei Finalisten stehen fest” (Mar 6, 2019) and “Die Top Ten Kandidaten des ZKB Pionierpreis Technopark stehen fest” (Jan 24, 2019).

Is Dicronis GmbH still active?

Yes, Dicronis GmbH is active; its latest activity on Parsers VC dates from Aug 21, 2019.